Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms

E.M. Hol, R.F. Roelofs, E. Moraal, M.A.F. Sonnemans, J.A. Sluijs, E.A. Proper, P.N.E. de Graan, D.F. Fischer, F.W. van Leeuwen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Glial fibrillary acidic protein (GFAP) is considered to be a highly specific marker for glia. Here, we report on the expression of GFAP in neurons in the human hippocampus. Intriguingly, this neuronal GFAP is coded by out-of-frame splice variants and its expression is associated with Alzheimer pathology. We identified three novel GFAP splice forms: Delta 135 nt, Delta exon 6 and Delta 164 nt. Neuronal GFAP is mainly observed in the pyramidal neurons of the hippocampus of Alzheimer and Down syndrome patients and aged controls, but not in neurons of patients suffering from hippocampal sclerosis. Apparently, the hippocampal neurons in patients with Alzheimer's disease pathology are capable of expressing glia-specific genes.

Original languageEnglish
Pages (from-to)786-796
Number of pages11
JournalMolecular Psychiatry
Volume8
Issue number9
DOIs
Publication statusPublished - Sept 2003

Keywords

  • Alternative Splicing
  • Alzheimer Disease
  • Amino Acid Sequence
  • Base Sequence
  • Down Syndrome
  • Epilepsy, Temporal Lobe
  • Exons
  • Female
  • Frameshifting, Ribosomal
  • Glial Fibrillary Acidic Protein
  • Hippocampus
  • Humans
  • Male
  • Molecular Sequence Data
  • Neuroglia
  • Neurons
  • RNA, Messenger
  • Reading Frames
  • Sclerosis
  • Transcription, Genetic
  • Comparative Study
  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms'. Together they form a unique fingerprint.

Cite this